Literature DB >> 938141

Treatment of malignant pleural effusion: a method using tube thoracostomy and talc.

R H Adler, I Sayek.   

Abstract

Our experience with a simple bedside method for controlling recurrent symptomatic malignant pleural effusion is presented. The method consists of intercostal tube thoracostomy, instillation of a suspension of talc, and waterseal suction drainage. Based on our experience, we believe certain criteria should be met before undertaking talc pleurodesis. In properly selected patients the results with tube thoracostomy and talc pleurodesis have been uniformly good in preventing fluid recurrence and return of disabling symptoms. The technique and results are discussed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 938141     DOI： 10.1016/s0003-4975(10)63944-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN： 0003-4975            Impact factor:   4.330


  12 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Pleurodesis for effusions in pediatric oncology patients at end of life.

Authors:  Fredric A Hoffer; Michael L Hancock; Pamela S Hinds; Nikita Oigbokie; Shesh N Rai; Bhaskar Rao
Journal:  Pediatr Radiol       Date:  2007-01-04

3.  Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions.

Authors:  M Morales; M C Expósito
Journal:  Support Care Cancer       Date:  1995-03       Impact factor: 3.603

Review 4.  Update in cancer chemotherapy, Part IV. Lung cancer, Part 2.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1985-11       Impact factor: 1.798

5.  Chylothorax: an omnipresent reality in thoracic surgical procedures.

Authors:  V E Ajanwachuku; S M Siram; O G Warner; L D Leffall
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

6.  Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion.

Authors:  Carolyn M Dresler; Jemi Olak; James E Herndon; William G Richards; Ernest Scalzetti; Stewart B Fleishman; Kemp H Kernstine; Todd Demmy; David M Jablons; Leslie Kohman; Thomas M Daniel; George B Haasler; David J Sugarbaker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

7.  Management of recurrent malignant pleural effusion with chemical pleurodesis.

Authors:  Dalokay Kilic; Hadi Akay; Sevket Kavukçu; Hakan Kutlay; Ayten Kayi Cangir; Serkan Enön; Cem Kadilar
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

8.  Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions.

Authors:  A G Villanueva; A W Gray; D M Shahian; W A Williamson; J F Beamis
Journal:  Thorax       Date:  1994-01       Impact factor: 9.139

9.  The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.

Authors:  H Suzuki; S Abo; M Kitamura; M Hashimoto; K Izumi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

Review 10.  Diagnosis and treatment of malignant pleural effusion.

Authors:  F H Hausheer; J W Yarbro
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.